TY - CHAP M1 - Book, Section TI - Ovarian Cancer A1 - Smith, Judith A. A2 - Chisholm-Burns, Marie A. A2 - Schwinghammer, Terry L. A2 - Malone, Patrick M. A2 - Kolesar, Jill M. A2 - Bookstaver, P. Brandon A2 - Lee, Kelly C. PY - 2022 T2 - Pharmacotherapy Principles & Practice, 6e AB - LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:Demonstrate understanding of the etiology and risk factors associated with the development of ovarian cancer.Justify the risk and benefits of the surgical and chemoprevention options available for decreasing the potential risk of developing ovarian cancer.Interpret and understand the utility of the screening tests and serologic markers for diagnosing ovarian cancer.Distinguish the nonspecific physical signs and symptoms of ovarian cancer.Recommend the appropriate surgical and chemotherapy treatment options for newly diagnosed, persistent, and recurrent ovarian cancer patients.Discuss the role of first-line maintenance treatment for improving overall survival for ovarian cancer patients.Compare and contrast chemotherapy options for women with recurrent platinum-resistant ovarian cancer. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/06 UR - ppp.mhmedical.com/content.aspx?aid=1187022745 ER -